Chalcogenoxanthylium photosensitizers for the photodynamic purging of blood-borne viral and bacterial pathogens

被引:29
|
作者
Wagner, SJ
Skripchenko, A
Donnelly, DJ
Ramaswamy, K
Detty, MR [1 ]
机构
[1] SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA
[2] Amer Red Cross, Holland Lab Biomed Sci, Rockville, MD 20855 USA
[3] SUNY Buffalo, Dept Biol, Buffalo, NY 14260 USA
关键词
chalcogenoxanthylium dyes; pathogen inactivation; photodynamic therapy; virus inactivation; bacterial inactivation;
D O I
10.1016/j.bmc.2005.07.035
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Thio- and selenoxanthylium dyes were prepared by the addition of 2-lithiothiophene, 4-N, N-dimethylaminophenylmagnesium bromide, and 1-naphthylmagnesium bromide to the appropriate 2,7-bis-N,N-dimethylaminochalcogenoxantlieti-9-one, followed by dehydration and ion exchange to the chloride salts. The corresponding chalcogenoxanthylium dyes were evaluated as photosensitizers for the inactivation of intracellular and extracellular virus in red blood cell suspensions and for the inactivation of selected strains of gram (+) and gram (-) bacteria in red blood cell Suspensions. Selected combinations of photosensitizer and light gave > 6log(10) inactivation of intracellular and extracellular virus, and > 4log(10) inactivation of extracellular bacteria with varying levels of hemolyis, following a 42-day storage of red blood cell suspensions. Photocleavage experiments with plasmid DNA and the chalcogenoxanthylium dyes suggested the genomic material contained in the virus and in the bacteria as one possible target for the photodynamic action of some of these dyes. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5927 / 5935
页数:9
相关论文
共 50 条
  • [1] Chalcogenoxanthylium photosensitizers for use in photodynamic therapy (PDT) and photodynamic purging of blood-borne viral and bacterial pathogens
    Donnelly, DJ
    Detty, MR
    Gibson, SL
    Hilf, R
    Wagner, SI
    Skripchenko, A
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2629 - U2629
  • [2] BLOOD-BORNE PATHOGENS IN SPORTS
    KARJALAINEN, J
    FRIMAN, G
    [J]. ANNALS OF INTERNAL MEDICINE, 1995, 123 (08) : 635 - 636
  • [3] Blood-borne pathogens and nosocomial infections
    Goldmann, DA
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 110 (02) : S21 - S26
  • [4] BLOOD-BORNE PATHOGENS IN SPORTS - REPLY
    MAST, EE
    GOODMAN, RA
    DROTMAN, DP
    [J]. ANNALS OF INTERNAL MEDICINE, 1995, 123 (08) : 636 - 636
  • [6] Standardization of NAT for Blood-Borne Pathogens
    Baylis, Sally A.
    Chudy, Michael
    Nuebling, C. Micha
    [J]. TRANSFUSION MEDICINE AND HEMOTHERAPY, 2015, 42 (04) : 211 - 218
  • [7] Human immunodeficiency virus and other blood-borne viral pathogens in the athletic setting
    Anderson, SJ
    Griesemer, BA
    Johnson, MD
    Martin, TJ
    McLain, LG
    Rowland, TW
    Small, E
    LeBlanc, C
    Krein, C
    Malina, R
    Young, JC
    Liaisons, S
    Reed, FE
    Washington, RL
    Risser, WL
    [J]. PEDIATRICS, 1999, 104 (06) : 1400 - 1403
  • [8] BLOOD-BORNE VIRAL-INFECTIONS
    GURTLER, L
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1994, 5 : S5 - S12
  • [9] Still in Focus: Assessment of Blood-Borne Pathogens
    Seitz, Rainer
    Heiden, Margarethe
    Offergeld, Ruth
    Burger, Reinhard
    [J]. TRANSFUSION MEDICINE AND HEMOTHERAPY, 2009, 36 (01) : 5 - 6
  • [10] REDUCING JOB EXPOSURE TO BLOOD-BORNE PATHOGENS
    MARWICK, C
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (01): : 17 - 17